Hostname: page-component-848d4c4894-75dct Total loading time: 0 Render date: 2024-06-10T21:15:11.925Z Has data issue: false hasContentIssue false

Intracellular distribution of antitumor Ru (II) compounds: The lysosome and the lysosomal enzymes as targets for anticancer metal-based drugs

Published online by Cambridge University Press:  06 August 2013

F. Marques
Affiliation:
Unidade Ciências Químicas e Radiofarmacêuticas, Instituto Superior Técnico, Polo de Loures-Campus Tecnológico e Nuclear, EN 10, 2685-953 Sacavém, Portugal
L. Corte-Real
Affiliation:
Unidade Ciências Químicas e Radiofarmacêuticas, Instituto Superior Técnico, Polo de Loures-Campus Tecnológico e Nuclear, EN 10, 2685-953 Sacavém, Portugal
A.P. Alves de Matos
Affiliation:
Anatomia Patológica, Centro Hospitalar de Lisboa Central - HCC, Rua da Beneficência 8, 1069-166 Lisboa, Portugal; Centro de Estudos do Ambiente e do Mar (CESAM/FCUL) – Faculdade de Ciências da Universidade de Lisboa and Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), Quinta da Granja, Monte de Caparica, 2829-511 Caparica, Portugal
I. Alho
Affiliation:
Laboratório de Genética, Faculdade de Medicina de Lisboa, Avª. Prof. Egas Moniz, 1649-028 Lisboa, Portugal
T.S. Morais
Affiliation:
Centro de Ciências Moleculares e Materiais, Faculdade de Ciências da Universidade de Lisboa, Campo Grande, 1149-016 Lisboa, Portugal
A.I. Tomaz
Affiliation:
Centro de Ciências Moleculares e Materiais, Faculdade de Ciências da Universidade de Lisboa, Campo Grande, 1149-016 Lisboa, Portugal
M.H. Garcia
Affiliation:
Centro de Ciências Moleculares e Materiais, Faculdade de Ciências da Universidade de Lisboa, Campo Grande, 1149-016 Lisboa, Portugal
M.P. Bicho
Affiliation:
Laboratório de Genética, Faculdade de Medicina de Lisboa, Avª. Prof. Egas Moniz, 1649-028 Lisboa, Portugal

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The therapeutic usefulness of anticancer agents relies on their ability to kill cancer cells while sparing normal cells and tissues. Ruthenium complexes hold great potential as suitable alternative drugs to the current cisplatin in the treatment of cancer. Our approach in this field has been the study of organoruthenium complexes, [RuII5-Cp)] family, namely [RuII5-Cp)(bipy)(PPh3)]+ (PPh3 = triphenylphosphine; bipy = 2,2’-bipyridine), TM34. This compound was tested for antitumor activity against tumor cells representative of human cancer diseases. A large spectrum of activity was found, largely surpassing cisplatin in efficacy (Fig 1).

How a drug distributes and localizes within cells is of fundamental importance as the drug must concentrate in the compartment that houses its target(s). The importance of cellular enzymes on the effects of anticancer drugs for which multiple biological pathways have been proposed led us to address the involvement of the lysosomes and lysosomal enzymes (AcPases) in the mechanism of cell death.

The cytotoxicity of TM34 was tested using the MTT assay. TM34 cellular distribution was measured by ICP-MS. The effect of TM34 on the activity of acid phosphatase (AcPase) was evaluated by the hydrolysis of p-nitrophenyl phosphate to p-nitrophenol. AcPase localization was investigated by TEM using the Record and Griffing (1988) cerium-based method.

Results showed that the sensitivity of AcPase assay is higher in comparison to cell proliferation assays based on the reduction of tetrazolium salts (MTT) (Fig 2). From TEM images AcPase reaction product appears as dark electron dense deposits in the lysosomes and dictiosomes. After 3h treatment TM34 provokes disruption and vesiculation of the Golgi apparatus, although some reaction product is present in the lysosomes (Fig 2).

The lysosome could be considered a possible target for TM34. Morphological evidence was observed for the participation of the Golgi apparatus in the vesiculation induced by the compound.

Supported by the Fundação para a Ciência e Tecnologia (FCT): PTDC/QUI-QUI/101187/2008.

Type
Life Sciences
Copyright
Copyright © Microscopy Society of America 2013